000258389 001__ 258389
000258389 005__ 20181203025123.0
000258389 02470 $$2isi$$a000424080200026
000258389 0247_ $$2doi$$a10.1080/2162402X.2017.1377874
000258389 037__ $$aARTICLE
000258389 245__ $$aATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy
000258389 269__ $$a2018
000258389 260__ $$c2018
000258389 336__ $$aJournal Articles
000258389 700__ $$aHarwood, SL
000258389 700__ $$aAlvarez-Cienfuegos, A
000258389 700__ $$aNunez-Prado, N
000258389 700__ $$aCompte, M
000258389 700__ $$aHernandez-Perez, S
000258389 700__ $$aMerino, N
000258389 700__ $$aBonet, J
000258389 700__ $$aNavarro, R
000258389 700__ $$aHenegouwen, PMPVE
000258389 700__ $$aLykkemark, S
000258389 700__ $$aMikkelsen, K
000258389 700__ $$aMolgaard, K
000258389 700__ $$aJabs, F
000258389 700__ $$aSanz, L
000258389 700__ $$aBlanco, FJ
000258389 700__ $$aRoda-Navarro, P
000258389 700__ $$aAlvarez-Vallina, L
000258389 773__ $$k1$$j7$$tONCOIMMUNOLOGY
000258389 909C0 $$xU13000$$0252545$$pLPDI
000258389 909CO $$pSTI$$particle$$ooai:infoscience.epfl.ch:258389
000258389 973__ $$aEPFL$$rREVIEWED$$sPUBLISHED
000258389 980__ $$aARTICLE
000258389 980__ $$aWoS